Skip to content
Israel Biotech Fund
  • About
  • Strategy
  • Portfolio
  • Team
  • Advisors
  • Partnerships
  • News
  • Contact
  • Investors
◀︎ All News

Merck, Pfizer, AstraZeneca and Teva join forces with Amazon & IBF in the launch of a new Israel-based AI incubator

October 14th, 2021 by IBF
Categories Uncategorized
Advaxis and Biosight Announce Entry into Definitive Merger Agreement
Israeli drug developer, Vensica Therapeutics, raises $16m in an investment round led by IBF
© 2026 Israel Biotech Fund • Built with GeneratePress